Compare, Analyse Elder Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ELDER PHARMA   ACTAVIS
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
ACTAVIS
Dec-18
ELDER PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs38014,145-   
Low Rs1889,488-   
Sales per share (Unadj.) Rs491.23,469.7-  
Earnings per share (Unadj.) Rs-3.2-1,117.6-  
Cash flow per share (Unadj.) Rs14.4365.6-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.514,311.0-  
Shares outstanding (eoy) m20.54332.60-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.63.4 17.0%   
Avg P/E ratio x-89.3-10.6 844.2%  
P/CF ratio (eoy) x19.732.3 61.0%  
Price / Book Value ratio x0.80.8 91.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,8333,930,206 0.1%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m2,1790-   
Avg. sales/employee Rs ThNM68,285.8-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-21,994.9-  
INCOME DATA
Net Sales Rs m10,0891,154,030 0.9%  
Other income Rs m25722,069 1.2%   
Total revenues Rs m10,3461,176,099 0.9%   
Gross profit Rs m-79230,241 -2.6%  
Depreciation Rs m361493,323 0.1%   
Interest Rs m2,75666,594 4.1%   
Profit before tax Rs m-3,653-507,606 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,713129,460 2.9%   
Tax Rs m125-6,433 -1.9%   
Profit after tax Rs m-65-371,714 0.0%  
Gross profit margin %-7.82.6 -299.5%  
Effective tax rate %-3.41.3 -270.3%   
Net profit margin %-0.6-32.2 2.0%  
BALANCE SHEET DATA
Current assets Rs m9,240473,323 2.0%   
Current liabilities Rs m9,998418,717 2.4%   
Net working cap to sales %-7.54.7 -158.7%  
Current ratio x0.91.1 81.8%  
Inventory Days Days4620 236.5%  
Debtors Days Days6066 90.4%  
Net fixed assets Rs m10,124130,630 7.7%   
Share capital Rs m2060-   
"Free" reserves Rs m5,5820-   
Net worth Rs m7,7344,759,833 0.2%   
Long term debt Rs m4,8891,676,110 0.3%   
Total assets Rs m22,8827,440,703 0.3%  
Interest coverage x-0.3-6.6 4.9%   
Debt to equity ratio x0.60.4 179.5%  
Sales to assets ratio x0.40.2 284.3%   
Return on assets %11.8-4.1 -286.8%  
Return on equity %-0.8-7.8 10.8%  
Return on capital %22.3-4.8 -460.9%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Net fx Rs m1810-   
CASH FLOW
From Operations Rs m11,754412,291 2.9%  
From Investments Rs m-561226,500 -0.2%  
From Financial Activity Rs m-6,762-707,615 1.0%  
Net Cashflow Rs m4,432-68,480 -6.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.1 Rs / USD

Compare ELDER PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ELDER PHARMA With: JUBILANT PHARMOVA   PROCTER & GAMBLE HEALTH  AUROBINDO PHARMA  SANOFI INDIA  NOVARTIS  



Today's Market

Sensex, Nifty End at Record Closing High; Tata Steel and Coal India Among Top Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Laurus Labs Hits New Life High. Up 500%+ in One Year (Views On News)

Jun 8, 2021

Laurus Labs trades higher for the eight straight day, soars 73% in 3 months.

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

Lupin Gains 16% in a Month. Here's Why it Could Rally More (Views On News)

Jun 4, 2021

Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.

Orchid Pharma Shares Zoom 7,700% in Seven Months. More Gains Ahead? (Views On News)

Jun 3, 2021

Here's why Orchid Pharma shares have rallied 7,700% in seven months.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors (Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

Don't Break These 5 Intraday Trading Rules (Fast Profits Daily)

Jun 1, 2021

To become a better intraday trader, follow these rules religiously.

Is the RBI's 'Bubble Talk' Signalling a Market Crash? (Profit Hunter)

May 31, 2021

Is the Indian central bank correct in warning you about a market crash?

Rs 2 Trillion Stimulus Coming to a Stock Market Near You (Profit Hunter)

Jun 2, 2021

Get ready to profit from a massive stimulus that you've never seen before.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ELDER PHARMA

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

FEATURED VIDEOS

The 3-Word Secret to Earning Incredible Returns

Buy & Hold v/s In & Out Investing

An Investing System that Found 20 Winners in a Row

Top Pick for Next Decade

More Featured Videos

MARKET STATS